Calcium molecule linked to aggressive cancer, imaging technique shows

New research shows a particular calcium molecule is linked to aggressive cancers when it stops regulating itself properly, and researchers at Columbia University Medical Center are looking for ways to fix it, according to a recent report.

The molecules, part of a family called transient receptor potential channels, are proteins that line surfaces of the body, such as intestines, and help calcium permeate cells.

The specific molecule linked to cancer is TRPV6. Many TRPV6 molecules are found in tumor cells and patients who have higher quantities of it also seem to have more aggressive forms of cancer.

To find out how transient receptor potential channels guide calcium into the cell and how it can form diseases, Alexander Sobolevsky, PhD, an assistant professor in the department of biochemistry and molecular biophysics at Columbia University Medical Center, and his team are using a technique called x-ray crystallography. The process allows them to map out a 3D model of the protein.

"In [the] future, we could use this model to design drugs that can target some types of tumor cells by plugging up TRP channels on their surfaces," Sobolevsky said in a statement.

 

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.